Myogenic Cell Differentiation via GSK3 and cAMP Pathway Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in efficiently differentiating embryonic stem cells and induced pluripotent stem cells into well-differentiated muscle cells, particularly for muscle regeneration and repair, due to limited expansion potential and lack of effective differentiation pathways.
Innovation Solution
A method involving culturing stem cells with a GSK3 pathway inhibitor, a compound that increases intracellular levels of cAMP, and a FGF pathway activator to induce differentiation into myogenic cells, which can be used for muscle regeneration and repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If satellite cells are isolated from adult skeletal muscle for therapy, then muscle regeneration and repair can be achieved, but the paucity of isolatable satellite cells limits the effectiveness of this approach
Solution Approach 1:
The patent uses embryonic stem cells and induced pluripotent stem cells as intermediary cells to generate satellite cells in vitro. These pluripotent stem cells serve as a mediator between available cell sources and the desired satellite cell population, allowing expansion beyond the limited number of directly isolatable satellite cells from adult muscle
Solution Approach 2:
The patent employs preliminary genetic manipulation and cell sorting approaches to pre-determine the myogenic differentiation pathway of stem cells before transplantation. By pre-programming the differentiation potential of stem cells through genetic modifications and selective sorting, the method ensures that the transplanted cells will effectively regenerate muscle tissue
2Quantity of substance
If embryonic stem cells and induced pluripotent stem cells are used for muscle regeneration, then an unlimited supply of myogenic cells can be generated, but the lack of effective differentiation pathways prevents well-differentiated muscle cell formation
Solution Approach 1:
The patent applies preliminary genetic manipulation to stem cells to pre-establish myogenic differentiation potential before transplantation. By introducing specific genetic modifications and using cell sorting techniques in advance, the method prepares the stem cells to reliably differentiate into muscle cells upon transplantation, ensuring both quantity and quality of the resulting myogenic cells
Solution Approach 2:
The patent utilizes small molecules to modulate signaling pathways and change the differentiation parameters of stem cells. By adjusting chemical parameters and signaling pathway activation states through small molecule compounds, the method directs stem cell differentiation toward the myogenic lineage with high efficiency and produces well-differentiated muscle cells
Data Source
AI summary
Disclosed are methods of inducing differentiation of stem into myogenic cells without gene manipulation and for inducing proliferation of satellite cells. The cells can be used as a source of cells for transplantation in a subject in need thereof. Also disclosed is a screening assay for screening test compounds using blastomere cultures.